Correlation Between Fresenius and Ono Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both Fresenius and Ono Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Fresenius and Ono Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Fresenius SE Co and Ono Pharmaceutical Co, you can compare the effects of market volatilities on Fresenius and Ono Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Fresenius with a short position of Ono Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Fresenius and Ono Pharmaceutical.
Diversification Opportunities for Fresenius and Ono Pharmaceutical
0.75 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Fresenius and Ono is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Fresenius SE Co and Ono Pharmaceutical Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ono Pharmaceutical and Fresenius is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Fresenius SE Co are associated (or correlated) with Ono Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ono Pharmaceutical has no effect on the direction of Fresenius i.e., Fresenius and Ono Pharmaceutical go up and down completely randomly.
Pair Corralation between Fresenius and Ono Pharmaceutical
Assuming the 90 days horizon Fresenius SE Co is expected to generate 0.77 times more return on investment than Ono Pharmaceutical. However, Fresenius SE Co is 1.3 times less risky than Ono Pharmaceutical. It trades about -0.06 of its potential returns per unit of risk. Ono Pharmaceutical Co is currently generating about -0.27 per unit of risk. If you would invest 924.00 in Fresenius SE Co on August 29, 2024 and sell it today you would lose (44.00) from holding Fresenius SE Co or give up 4.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 98.44% |
| Values | Daily Returns |
Fresenius SE Co vs. Ono Pharmaceutical Co
Performance |
| Timeline |
| Fresenius SE |
| Ono Pharmaceutical |
Fresenius and Ono Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Fresenius and Ono Pharmaceutical
The main advantage of trading using opposite Fresenius and Ono Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Fresenius position performs unexpectedly, Ono Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ono Pharmaceutical will offset losses from the drop in Ono Pharmaceutical's long position.| Fresenius vs. Jack Nathan Medical | Fresenius vs. Medical Facilities | Fresenius vs. Ramsay Health Care | Fresenius vs. Nova Leap Health |
| Ono Pharmaceutical vs. Santen Pharmaceutical Co | Ono Pharmaceutical vs. GSK plc | Ono Pharmaceutical vs. Grifols SA ADR | Ono Pharmaceutical vs. Pfizer Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |